Protalix BioTherapeutics
PLX
#8907
Rank
S$0.18 B
Marketcap
S$2.26
Share price
0.58%
Change (1 day)
-4.41%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): S$12.1 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$61.94 Million. In 2024 the company made an earning of S$6.76 Million a decrease over its 2023 earnings that were of S$15.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$12.1 M78.97%
2024 S$6.76 M-55.62%
2023 S$15.24 M-199.05%
2022 -S$15.39 Million-40.38%
2021 -S$25.82 Million-732.31%
2020 S$4.08 M-130.53%
2019 -S$13.37 Million189.85%
2018 -S$4.62 Million-95.29%
2017 -S$97.97 Million308.12%
2016 -S$24.01 Million-32.37%
2015 -S$35.5 Million10.11%
2014 -S$32.24 Million-7.59%
2013 -S$34.89 Million
2011 -S$40.4 Million-19.39%
2010 -S$50.11 Million20.87%
2009 -S$41.46 Million32.26%
2008 -S$31.35 Million-5.46%
2007 -S$33.16 Million
2004 -S$0.22 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.22 Million-57.03%
2001 -S$0.51 Million1.03%
2000 -S$0.5 Million-53.22%
1999 -S$1.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
S$6.46 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.75 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.36 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.29 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel